Lori Fischl
Surgical · Wilmington, NCNPI 1538230560
Payments from drug & device makers
Across 53 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$258
- Boston Scientific$125
- Johnson & Johnson$120
- Organogenesis Inc.$77
- Pfizer$54
- Biowound Solutions, Inc.$47
- plus $368 from 16 others
What the payments were for
- Food & beverage$1,050100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 14 | $258 |
| Boston Scientific | 6 | $125 |
| Johnson & Johnson(2 entities) | 6 | $120 |
| Organogenesis Inc. | 2 | $77 |
| Pfizer | 3 | $54 |
| Biowound Solutions, Inc. | 1 | $47 |
| Convatec Inc. | 1 | $34 |
| Cashflow Solutions, LLC | 4 | $34 |
| Stryker | 1 | $32 |
| Solventum Corporation | 2 | $31 |
| Bard Peripheral Vascular, Inc. | 1 | $27 |
| BD | 1 | $25 |
| Sanara Medtech Inc. | 2 | $25 |
| Inari Medical, Inc. | 1 | $23 |
| Medtronic | 1 | $22 |
| Neuros Medical, Inc. | 1 | $21 |
| Kerecis Limited | 1 | $19 |
| Shockwave Medical, Inc | 1 | $19 |
| Merit Medical Systems Inc | 1 | $17 |
| Next Science LLC | 1 | $14 |
| Triad Life Sciences Inc. | 1 | $13 |
| Cardiovascular Systems Inc. | 1 | $12 |
How this compares
$1,050 in reported general payments places this provider in the 70th percentile of 248 surgical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $15,237 |
| BrilintaTicagrelor | 11 | $4,721 |
| Cilostazol | 127 | $1,969 |
| ClopidogrelClopidogrel Bisulfate | 167 | $1,689 |
| Gabapentin | 14 | $419 |
| Ciprofloxacin Hcl | 28 | $186 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 71 | $175 |
| Atorvastatin Calcium | 20 | $109 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $99 |
| Doxycycline Hyclate | 11 | $95 |
| Diazepam | 53 | $90 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $54 | $15,23722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 248 surgical providers in North Carolina.
Other surgical in Wilmington
- Lawrence LandriganWilmington$12K
- Sheila AndersonWilmington$10K
- Megan McNamaraWilmington$9K
- Jeffrey ProbstWilmington$5K
- Christopher SteyskalWilmington$3K
- Chase WhelanWilmington$2K
- Kevan HaasChapel Hill$44K
- Erika LynchLeland$10K
- Christopher CraigWinston Salem$9K
- Anna LandenDurham$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.